GSK3 hyperactivity has been linked to neurodegeneration before, mainly to Alzheimer’s Disease (AD), and recent studies suggested a possible role of GSK3 in FUS and TDP-43 ALS [58–60]. This evidence concerns the gene FUS and early-onset autosomal dominant Alzheimer disease.